Platelet-Derived Growth Factor-Receptor α Strongly Inhibits Melanoma Growth In Vitro and In Vivo
Cutaneous melanoma is the most aggressive skin cancer; it is highly metastatic and responds poorly to current therapies. The expression of platelet-derived growth factor receptors (PDGF-Rs) is reported to be reduced in metastatic melanoma compared with benign nevi or normal skin; we then hypothesiz...
Main Authors: | Debora Faraone, Maria Simona Aguzzi, Gabriele Toietta, Angelo M. Facchiano, Francesco Facchiano, Alessandra Magenta, Fabio Martelli, Silvia Truffa, Eleonora Cesareo, Domenico Ribatti, Maurizio C. Capogrossi, Antonio Facchiano |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-08-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558609801292 |
Similar Items
-
RAM, an RGDS analog, exerts potent anti-melanoma effects in vitro and in vivo.
by: Maria Simona Aguzzi, et al.
Published: (2011-01-01) -
Intracellular targets of RGDS peptide in melanoma cells
by: Capogrossi Maurizio C, et al.
Published: (2010-04-01) -
An investigation into the molecular basis of cancer comorbidities in coronavirus infection
by: Antonio Facchiano, et al.
Published: (2020-11-01) -
Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular Targets
by: Daniela D’Arcangelo, et al.
Published: (2019-03-01) -
WIPI1, BAG1, and PEX3 Autophagy-Related Genes Are Relevant Melanoma Markers
by: Daniela D’Arcangelo, et al.
Published: (2018-01-01)